PHP131 How Can Pharma Industry Prepare Itself for the Changing Pricing and Reimbursement Landscape of Orphan Drugs in EU?

Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.682
https://www.valueinhealthjournal.com/article/S1098-3015(11)02244-3/fulltext
Section Title : Health Care Use & Policy Studies
Section Order : 652
First Page : A357
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02244-3&doi=10.1016/j.jval.2011.08.682
HEOR Topics :
Tags :
Regions :